Sarepta Therapeutics to Restructure, Lay Off 500 Workers The Wall Street Journal Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label Sarepta Therapeutics Sarepta Stock Soars 30%. Why Layoffs and a ‘Black-Box’ Warning Are Good News. Barron’s Sarepta Soars as Gene Therapy Stays on Market With Warning Bloomberg Sarepta Tags DMD Gene Therapy …
Read More »Tag Archives: Therapeutics
Sarepta Therapeutics lays off one-third of workforce in drastic cost-cutting move
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. You can reach Adam on Signal at stataf.54. Sarepta Therapeutics laid off more than one-third of its workforce, …
Read More »Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label – Sarepta Therapeutics
Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label Sarepta TherapeuticsView Full Coverage on Google News Source link
Read More »